广药集团旗下白云山生物冻干人用狂犬病疫苗（Vero细胞）获批生产

Core Viewpoint - Guangzhou Pharmaceutical Group's subsidiary, Baiyunshan Biological, has received approval from the National Medical Products Administration for its "Lyophilized Human Rabies Vaccine (Vero Cell)" registration certificate, marking a significant advancement in rabies prevention products [1] Group 1: Product Details - The approved rabies vaccine is a self-developed biological product aimed at preventing rabies [1] - The vaccine is free from gelatin, antibiotics, and preservatives, ensuring a safer formulation [1] - Clinical trials indicate that the vaccine demonstrates good immunogenicity when administered in either a 5-dose or 4-dose regimen to healthy individuals aged 10-60 [1]